Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HW
476
DELISTED
Headwaters Inc
HW
| $18.7M | 0.05% |
+2,115,000
| New | +$21.8M |
|
|
RTK
477
DELISTED
Rentech, Inc.
RTK
| $18.7M | 0.05% |
+890,320
| New | +$19.2M |
|
478
Evercore
EVR
$11.6B
| $18.7M | 0.05% |
+475,300
| New | +$18.4M |
|
479
Devon Energy
DVN
$49.6B
| $18.6M | 0.05% |
+358,100
| New | +$19.9M |
|
|
CIT
480
DELISTED
CIT Group Inc.
CIT
| $18.6M | 0.05% |
+398,300
| New | +$17.6M |
|
481
Cleveland-Cliffs
CLF
$6.91B
| $18.6M | 0.05% |
+1,142,800
| New | +$21.9M |
|
482
Portland General Electric
POR
$5.73B
| $18.5M | 0.05% |
+605,200
| New | +$18.8M |
|
|
ARTC
483
DELISTED
ARTHROCARE CORP
ARTC
| $18.5M | 0.05% |
+534,400
| New | +$18.4M |
|
|
STMP
484
DELISTED
Stamps.com, Inc.
STMP
| $18.4M | 0.05% |
+467,251
| New | +$15.6M |
|
485
ICU Medical
ICUI
$4.46B
| $18.3M | 0.05% |
+253,600
| New | +$16.8M |
|
486
Children's Place
PLCE
$55.6M
| $18.2M | 0.05% |
+332,560
| New | +$16.8M |
|
|
ALR
487
DELISTED
Alere Inc
ALR
| $18.2M | 0.05% |
+741,124
| New | +$19.2M |
|
488
WD-40
WDFC
$3.12B
| $18.1M | 0.05% |
+332,300
| New | +$18.3M |
|
489
Sally Beauty Holdings
SBH
$1.51B
| $18M | 0.05% |
+579,800
| New | +$17.5M |
|
|
WP
490
DELISTED
Worldpay, Inc.
WP
| $18M | 0.05% |
+653,000
| New | +$16.2M |
|
|
INVX
491
Innovex International
INVX
$2.13B
| $18M | 0.05% |
+199,100
| New | +$17.4M |
|
|
VER
492
DELISTED
VEREIT, Inc.
VER
| $18M | 0.05% |
+235,520
| New | +$18.8M |
|
493
Howard Hughes
HHH
$3.95B
| $17.9M | 0.05% |
+167,945
| New | +$15.8M |
|
494
Radian Group
RDN
$4.89B
| $17.9M | 0.05% |
+1,543,700
| New | +$18.7M |
|
|
BBBY
495
Bed Bath & Beyond
BBBY
$410M
| $17.9M | 0.05% |
+845,851
| New | +$14.2M |
|
496
Quanta Services
PWR
$103B
| $17.9M | 0.05% |
+677,199
| New | +$18.8M |
|
497
Equifax
EFX
$21.2B
| $17.9M | 0.05% |
+303,895
| New | +$18.3M |
|
498
Sabesp
SBS
$17.9B
| $17.9M | 0.05% |
+8,869,219
| New | +$23M |
|
499
Public Service Enterprise Group
PEG
$37.8B
| $17.9M | 0.05% |
+548,000
| New | +$18.7M |
|
500
Avery Dennison
AVY
$13.7B
| $17.8M | 0.05% |
+415,700
| New | +$17.7M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.